Live Chat

MerckCo USA 거래 MRK

MerckCo 실시간 차트

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

정보

스프레드

0.67

스프레드(%)

0.6188 %

레버리지

1:10

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 폐장

월요일

13:31 - 19:59

화요일

13:31-19:59

수요일

13:31-19:59

목요일

13:31-19:59

금요일

13:31-19:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

258221506560

발행 주식 수

2534810112

수익 날짜 (다음)

2021-06-03

배당수익률

2024-10-07

배당락일

2024-09-16

예상 연간 배당금

3.08

예상 연간 배당수익률

0.0302

EPS

4.77

이 상품에 대해 자세히 알아보기

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

최신 뉴스

전 세계의 최신 금융 뉴스를 받아보세요.

수요일, 6 11월 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

화요일, 5 11월 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

화요일, 5 11월 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

화요일, 5 11월 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

화요일, 5 11월 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

화요일, 5 11월 2024

Early Election Results Shift Markets as Trump’s Chances Rise

월요일, 4 11월 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

월요일, 4 11월 2024

US election: What will happen to tesla stock if Trump wins?

Trustpilot
Live Chat